U.K. agency endorses spinal cord stimulation for chronic pain

11/19/2008 | FDAnews

The U.K.'s National Institute for Health and Clinical Excellence has released a guidance recommending spinal cord stimulation for individuals who continue to suffer from chronic pain for at least six months after using traditional methods to relieve the problem. NICE's endorsement clears the way for National Health Service coverage of the therapy.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC